Gefitinib Genepharm

Gefitinib Genepharm is an oral medication used to target specific proteins in cancer cells. This treatment is designed for targeted therapy in certain types of cancer.

Gefitinib Genepharm is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It works by targeting specific proteins involved in cancer cell growth. This medication is often considered when the cancer has specific genetic markers that make it responsive to gefitinib.

Common effects of Gefitinib Genepharm may include skin rash, diarrhea, and appetite loss. Some users may also experience dry skin, nausea, or fatigue. These effects can vary in intensity and duration among individuals.

Gefitinib Genepharm should be handled with care, especially by those with pre-existing liver or kidney conditions. It is important to follow the advice of a healthcare provider regarding its use. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Gefitinib Genepharm may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.